Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH 497079 plus desloratadine for nasal congestion in seasonal allergic rhinitis after pollen challenge
2004-001883-39Phase 2Completed
- Sponsor
- Schering-Plough Research Institute
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of SCH 497079 and desloratadine in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Schering-Plough Research Institute. Primary endpoint: Average change from baseline in subjectively evaluated nasal congestion over 7.5 hours. Started Dec 2004; status: completed.
02
Drugs
SCH 497079desloratadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2004-001883-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001883-39.